Cliff Asness, AQR Capital Like Exxon Too, Also Bullish on Chevron
Cliff Asness and AQR Capital Management are bullish on oil stocks.
Posts Tagged ‘NYSE:PFE’
Investing in Counteracting Biological and Chemical Agents
Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures to these and biological...
Nektar Therapeutics (NKTR), Pfizer Inc. (PFE): What’s MannKind Corporation (MNKD) Really Worth?
This is close to the market cap that Bank of America's Steve Byrne thinks MannKind Corporation (NASDAQ:MNKD) is worth.
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
Bank of America Corp (BAC), American International Group Inc (AIG): When a Crisis Became a Catastrophe
Lehman Brothers filed for bankruptcy protection early in the morning on Sept. 15, 2008, after failing to find any company willing to acquire its immense liabilities.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ): Top Risk Factors for Heart Disease
Heart disease is the leading cause of death in the United States. In 2010, according to data from the Centers for Disease Control and Prevention, 597,689 people in the U.S.
Trius Therapeutics, Inc. (TSRX), Cubist Pharmaceuticals Inc (CBST), Pfizer Inc. (PFE): A Portfolio Of Potential
After the market closed on July 30, antibiotic expert Cubist Pharmaceuticals Inc (NASDAQ:CBST) announced two acquisitions worth up to a combined $1.6 billion.
Amgen, Inc. (AMGN), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): The Neulasta Question
In a couple of years, Amgen, Inc. (NASDAQ:AMGN) will have to face the music when the patent for its $4 billion a year drug, Neulasta, expires in the U.S. and Europe.
MannKind Corporation (MNKD), Pfizer Inc. (PFE): Why Afrezza May Not Work
MannKind Corporation (NASDAQ:MNKD) has been struggling to get its inhalable insulin product Afrezza on the market; the product was sent back to the labs by the Food and Drug Administration...
Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does This Orphan Leukemia Treatment Have Blockbuster Potential?
When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen.
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Will a Band-Aid Be Enough for Johnson & Johnson (JNJ)’s Latest Recall?
Johnson & Johnson (NYSE:JNJ) recently announced a recall of around 200,000 bottles of Motrin Infants' Drops Original Berry Flavor.
GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Theravance Inc (THRX) Gets Big Win for New COPD Drug
Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S.
Pfizer Inc. (PFE), Regeneron Pharmaceuticals Inc (REGN), Amgen, Inc. (AMGN): Invest in the Next Biotech Frontier
The last several months have been remarkably exciting in the biotech space.
Pfizer Inc. (PFE): Is Seattle Genetics (SGEN) an Acquisition Target?
In late August, Amgen agreed to buy Onyx Pharmaceuticals in one of the worst-kept M&A secrets of the year.
Incyte Corporation (INCY), Pfizer Inc. (PFE): This Biotech Has So Many Reasons to Be Liked
Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only approved drug, Jakafi...
Johnson & Johnson (JNJ), Forest Laboratories, Inc. (FRX), Pfizer Inc. (PFE): Pharmas Spending the Most to Catch Your Doctor’s Eye
Pharmaceutical firms spend a lot of money to influence physicians to prescribe their products.
Billionaire Ken Griffin Thinks Apple Inc. (AAPL) Is Cheap. What About His Other Picks?
Many investors and market watchers claim that quarterly 13Fs from hedge funds are of limited use to mom-and-pop traders.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Two Reasons This Biotech Hardly Moved After a Successful Trial
Adding Esperion Therapeutics' ECT-1002 to Pfizer Inc. (NYSE:PFE)'s Lipitor lowered bad LDL cholesterol levels by 22%.
Pfizer Inc. (PFE): Arena Pharmaceuticals, Inc. (ARNA) Pushes Forward
As much as I think Arena Pharmaceuticals, Inc.
Pfizer Inc. (PFE), Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Two Lucrative Drug Markets You Should Avoid
You really don't need both. There are enough people with rheumatoid arthritis or high cholesterol, for example, to have multiple blockbuster drugs that treat the diseases.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): The Biggest Winners of the FDA’s Breakthrough Designation
Designed as a way to bring potentially life-changing drugs to pharmacy shelves faster than ever, the Food and Drug Administration Safety and Innovation Act, which passed last ...
Lexicon Pharmaceuticals, Inc. (LXRX), Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Why Clinical Trials Fail
Drugs fail their clinical trials for all kinds of reasons. Sometimes, it's related to efficacy; sometimes, it's safety related.
Pfizer Inc. (PFE) & Johnson & Johnson (JNJ) In Billionaire David Shaw’s Top Dividend Picks
Many market watchers believe that quarterly 13F filings from hedge funds are of no use to most investors, but we have shown that this is false in at least one way: it is possible...
Pfizer Inc. (PFE), Zoetis Inc (ZTS), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): 5 Reasons to Invest in Animal Health
In an attempt to further simplify its business and unlock shareholder value, Pfizer Inc. (NYSE:PFE) has been busy divesting itself of non-core assets.
Hedge Funds Are Buying Novartis AG (ADR) (NVS)
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Pfizer Inc. (PFE): The Procter & Gamble Company (PG)’s Fall Can’t Stop the Dow Jones Industrial Average (.DJI)’s Bounce
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Can This HIV Drug Challenge Gilead Sciences, Inc. (GILD)’s Domination?
ViiV Healthcare -- a joint venture by Pfizer Inc.
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Which Pharmaceutical Giant Faces the Steepest Patent Cliff?
At the same time, the pharmaceutical industry isn't without its share of risks.
Pfizer Inc. (PFE), Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK) Among Hedge Funds’ Favorite Pharma Stocks
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors.
Amgen, Inc. (AMGN) and Onyx Pharmaceuticals, Inc. (ONXX): Half a Billion Dollars’ Worth of Drama
A finale has at last arrived for the biotech drama of summer 2013. Amgen, Inc. (NASDAQ:AMGN) announced yesterday that it will buy Onyx Pharmaceuticals, Inc.
Pfizer Inc. (PFE), Amgen, Inc. (AMGN), UnitedHealth Group Inc. (UNH): Do Health Care Stocks Fall in the Fall?
Every investor has heard the old line "sell in May and go away." That wasn't such great advice this year with the S&P 500 index up nearly 5% since the beginning of May.
Pfizer Inc. (PFE), United Therapeutics Corporation (UTHR): How Big Is Organovo Holdings Inc (ONVO)’s Market Opportunity?
Organovo Holdings Inc (NYSEMKT:ONVO) is a little company that people think could do big things.
ConocoPhillips (COP), Pfizer Inc. (PFE), Cytec Industries Inc (CYT): Forget Bernanke, Invest Alongside His Potential Successor
At StreetAuthority, we often look at where Washington's most powerful men are putting their money.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY), Forest Laboratories, Inc. (FRX): The Past, Present, and Future of Alzheimer’s Treatments
Editor’s Note: A previous version of this post incorrectly stated that Eli Lilly’s experimental drug solanezumab is a BACE inhibitor.
Is Sanofi SA (ADR) (SNY) Going to Burn These Hedge Funds?
To the average investor, there are plenty of gauges investors can use to track Mr. Market. Some of the most useful are hedge fund and insider trading interest.
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does Incyte Corporation (INCY) Deserve Its New Valuation?
One of the hottest stocks on the market Wednesday was Incyte Corporation (NASDAQ:INCY), a pharmaceutical company specializing in the development of JAK inhibitors.
Pfizer Inc. (PFE), United Therapeutics Corporation (UTHR): Organovo Holdings Inc (ONVO)’s Earnings, Patience Is Necessary
Imagine a day where there are no waiting lists for liver transplants. Instead, patients can have a perfectly tailored liver bioprinted and placed into their body.
Someone’s Selling Pfizer Inc. (PFE) Shares, Should You?
Now, according to many traders, hedge funds are seen as delayed, outdated investment tools of an era lost to time.
Pfizer Inc. (PFE), Regeneron Pharmaceuticals Inc (REGN): Are These Drugs the Future of High-Cholesterol Treatment?
Once upon a time in a regulatory environment far, far away, there was a cholesterol-fighting drug named Lipitor from Pfizer Inc. (NYSE:PFE).
Express Scripts Holding Company (ESRX), Community Health Systems (CYH), Pfizer Inc. (PFE): Why Health-Care Costs Are Likely to Rise
Opinions rage about whether health insurance costs will rise or fall with implementation of the Affordable Care Act, commonly known as Obamacare.
Johnson & Johnson (JNJ), Express Scripts Holding Company (ESRX), Gilead Sciences, Inc. (GILD): Three Great Buy-and-Hold Health-Care Stocks
This could have been an enormously more difficult effort. I started out with the goal to identify the three best stocks in health care to buy and hold for years, even decades.
AT&T Inc. (T), Intel Corporation (INTC), Pfizer Inc. (PFE): An Even Simpler Path to Dow Dividend Riches?
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Alarming New Obesity Data Points to a Scary Trend
Last week, the Trust for America's Health and the Robert Wood Johnson Foundation released their annual report (link opens a PDF to a 116-page report) on obesity trends in the ...
AT&T Inc. (T), Pfizer Inc. (PFE): Dow Jones Industrial Average (.DJI) Ends the Week With a Whimper as Verizon Communications Inc. (VZ) Drops
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...
MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): Dreamboat Data? Not Exactly.
MannKind Corporation (NASDAQ:MNKD) ended up more than 10% on Wednesday, after the biotech announced positive results for two phase 3 trials testing its inhaled insulin Afrezza...
Billionaire Stanley Druckenmiller Traded Homebuilders for Google Inc (GOOG) Last Quarter: Lennar Corporation (LEN), D.R. Horton, Inc. (DHI)
In August, billionaire Stanley Druckenmiller’s family office (Druckenmiller is the former head of Duquesne Capital) filed its 13F for the second quarter of 2013 with the SEC...
MannKind Corporation (MNKD): What’s the Latest: New Insulin Inhaler, Rating Reiterated by Zacks, Matthew J. Pfeffer & More
The long promise of insulin that diabetics can inhale appears to be moving closer to the market.
Organovo Holdings Inc (ONVO), 3D Systems Corporation (DDD): A Tiny 3-D Printing Company I’m Buying
Ever since August 2011, I've been calling out one or two companies every month that I was putting my own retirement money behind.
eBay Inc (EBAY), Pfizer Inc. (PFE): Does a PayPal Spinoff Make Sense?
The ideal situation for a spinoff is when you have a small, fast growing division lodged within a large, slower-growing company.
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): The 10 Most Common Reasons People Visit Their Doctor
With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the...
